ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Opioid Receptor Agonist Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-2Y10693
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Opioid Receptor Agonist Market Research Report 2022
BUY CHAPTERS

Global Opioid Receptor Agonist Market Research Report 2025

Code: QYRE-Auto-2Y10693
Report
March 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teva Pharmaceutical Industries
Johnson & Johnson
Pfizer Inc
Fresenius Kabi
Mylan N.V.
Allergan plc
US WorldMeds
Piramal Critical Care
Daiichi Sankyo Company
Purdue Pharma
Hikma Pharmaceuticals
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Tris Pharma

Opioid Receptor Agonist Market Size

The global market for Opioid Receptor Agonist was valued at US$ 907 million in the year 2024 and is projected to reach a revised size of US$ 1238 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Opioid Receptor Agonist Market

Opioid Receptor Agonist Market

Opioids are a type of painkiller that works by acting on the neurological system. They"re mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors" pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.
Opioids are a type of painkiller that works by acting on the neurological system. They"re mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors" pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Opioid Receptor Agonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Receptor Agonist.
The Opioid Receptor Agonist market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Receptor Agonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Receptor Agonist manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Opioid Receptor Agonist Market Report

Report Metric Details
Report Name Opioid Receptor Agonist Market
Accounted market size in year US$ 907 million
Forecasted market size in 2031 US$ 1238 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, Fresenius Kabi, Mylan N.V., Allergan, US WorldMeds, Piramal Critical Care, DAIICHI SANKYO COMPANY, Purdue Pharma, Hikma Pharmaceuticals, Endo Pharmaceuticals, Sun Pharmaceutical Industries, Tris Pharma, Indivior
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Opioid Receptor Agonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Opioid Receptor Agonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Opioid Receptor Agonist Market growing?

Ans: The Opioid Receptor Agonist Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Opioid Receptor Agonist Market size in 2031?

Ans: The Opioid Receptor Agonist Market size in 2031 will be US$ 1238 million.

Who are the main players in the Opioid Receptor Agonist Market report?

Ans: The main players in the Opioid Receptor Agonist Market are Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, Fresenius Kabi, Mylan N.V., Allergan, US WorldMeds, Piramal Critical Care, DAIICHI SANKYO COMPANY, Purdue Pharma, Hikma Pharmaceuticals, Endo Pharmaceuticals, Sun Pharmaceutical Industries, Tris Pharma, Indivior

What are the Application segmentation covered in the Opioid Receptor Agonist Market report?

Ans: The Applications covered in the Opioid Receptor Agonist Market report are Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Opioid Receptor Agonist Market report?

Ans: The Types covered in the Opioid Receptor Agonist Market report are Fentanyl, Codeine, Morphine, Others

Recommended Reports

Opioid and Agonists

Pain Relief/Analgesics

Receptor/Agonists Markets

1 Opioid Receptor Agonist Market Overview
1.1 Product Definition
1.2 Opioid Receptor Agonist by Type
1.2.1 Global Opioid Receptor Agonist Market Value Comparison by Type (2024 VS 2031)
1.2.2 Fentanyl
1.2.3 Codeine
1.2.4 Morphine
1.2.5 Others
1.3 Opioid Receptor Agonist by Application
1.3.1 Global Opioid Receptor Agonist Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Global Opioid Receptor Agonist Market Size Estimates and Forecasts
1.4.1 Global Opioid Receptor Agonist Revenue 2020-2031
1.4.2 Global Opioid Receptor Agonist Sales 2020-2031
1.4.3 Global Opioid Receptor Agonist Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Opioid Receptor Agonist Market Competition by Manufacturers
2.1 Global Opioid Receptor Agonist Sales Market Share by Manufacturers (2020-2025)
2.2 Global Opioid Receptor Agonist Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Opioid Receptor Agonist Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Opioid Receptor Agonist, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Opioid Receptor Agonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioid Receptor Agonist, Product Type & Application
2.7 Global Key Manufacturers of Opioid Receptor Agonist, Date of Enter into This Industry
2.8 Global Opioid Receptor Agonist Market Competitive Situation and Trends
2.8.1 Global Opioid Receptor Agonist Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Opioid Receptor Agonist Players Market Share by Revenue
2.8.3 Global Opioid Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Opioid Receptor Agonist Market Scenario by Region
3.1 Global Opioid Receptor Agonist Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Opioid Receptor Agonist Sales by Region: 2020-2031
3.2.1 Global Opioid Receptor Agonist Sales by Region: 2020-2025
3.2.2 Global Opioid Receptor Agonist Sales by Region: 2026-2031
3.3 Global Opioid Receptor Agonist Revenue by Region: 2020-2031
3.3.1 Global Opioid Receptor Agonist Revenue by Region: 2020-2025
3.3.2 Global Opioid Receptor Agonist Revenue by Region: 2026-2031
3.4 North America Opioid Receptor Agonist Market Facts & Figures by Country
3.4.1 North America Opioid Receptor Agonist Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Opioid Receptor Agonist Sales by Country (2020-2031)
3.4.3 North America Opioid Receptor Agonist Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Opioid Receptor Agonist Market Facts & Figures by Country
3.5.1 Europe Opioid Receptor Agonist Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Opioid Receptor Agonist Sales by Country (2020-2031)
3.5.3 Europe Opioid Receptor Agonist Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Opioid Receptor Agonist Market Facts & Figures by Region
3.6.1 Asia Pacific Opioid Receptor Agonist Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Opioid Receptor Agonist Sales by Region (2020-2031)
3.6.3 Asia Pacific Opioid Receptor Agonist Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Opioid Receptor Agonist Market Facts & Figures by Country
3.7.1 Latin America Opioid Receptor Agonist Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Opioid Receptor Agonist Sales by Country (2020-2031)
3.7.3 Latin America Opioid Receptor Agonist Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Opioid Receptor Agonist Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioid Receptor Agonist Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Opioid Receptor Agonist Sales by Country (2020-2031)
3.8.3 Middle East and Africa Opioid Receptor Agonist Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Opioid Receptor Agonist Sales by Type (2020-2031)
4.1.1 Global Opioid Receptor Agonist Sales by Type (2020-2025)
4.1.2 Global Opioid Receptor Agonist Sales by Type (2026-2031)
4.1.3 Global Opioid Receptor Agonist Sales Market Share by Type (2020-2031)
4.2 Global Opioid Receptor Agonist Revenue by Type (2020-2031)
4.2.1 Global Opioid Receptor Agonist Revenue by Type (2020-2025)
4.2.2 Global Opioid Receptor Agonist Revenue by Type (2026-2031)
4.2.3 Global Opioid Receptor Agonist Revenue Market Share by Type (2020-2031)
4.3 Global Opioid Receptor Agonist Price by Type (2020-2031)
5 Segment by Application
5.1 Global Opioid Receptor Agonist Sales by Application (2020-2031)
5.1.1 Global Opioid Receptor Agonist Sales by Application (2020-2025)
5.1.2 Global Opioid Receptor Agonist Sales by Application (2026-2031)
5.1.3 Global Opioid Receptor Agonist Sales Market Share by Application (2020-2031)
5.2 Global Opioid Receptor Agonist Revenue by Application (2020-2031)
5.2.1 Global Opioid Receptor Agonist Revenue by Application (2020-2025)
5.2.2 Global Opioid Receptor Agonist Revenue by Application (2026-2031)
5.2.3 Global Opioid Receptor Agonist Revenue Market Share by Application (2020-2031)
5.3 Global Opioid Receptor Agonist Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Teva Pharmaceutical Industries
6.1.1 Teva Pharmaceutical Industries Company Information
6.1.2 Teva Pharmaceutical Industries Description and Business Overview
6.1.3 Teva Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva Pharmaceutical Industries Opioid Receptor Agonist Product Portfolio
6.1.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Opioid Receptor Agonist Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Opioid Receptor Agonist Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Company Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Fresenius Kabi Opioid Receptor Agonist Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Mylan N.V.
6.5.1 Mylan N.V. Company Information
6.5.2 Mylan N.V. Description and Business Overview
6.5.3 Mylan N.V. Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan N.V. Opioid Receptor Agonist Product Portfolio
6.5.5 Mylan N.V. Recent Developments/Updates
6.6 Allergan
6.6.1 Allergan Company Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Allergan Opioid Receptor Agonist Product Portfolio
6.6.5 Allergan Recent Developments/Updates
6.7 US WorldMeds
6.7.1 US WorldMeds Company Information
6.7.2 US WorldMeds Description and Business Overview
6.7.3 US WorldMeds Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.7.4 US WorldMeds Opioid Receptor Agonist Product Portfolio
6.7.5 US WorldMeds Recent Developments/Updates
6.8 Piramal Critical Care
6.8.1 Piramal Critical Care Company Information
6.8.2 Piramal Critical Care Description and Business Overview
6.8.3 Piramal Critical Care Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Piramal Critical Care Opioid Receptor Agonist Product Portfolio
6.8.5 Piramal Critical Care Recent Developments/Updates
6.9 DAIICHI SANKYO COMPANY
6.9.1 DAIICHI SANKYO COMPANY Company Information
6.9.2 DAIICHI SANKYO COMPANY Description and Business Overview
6.9.3 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.9.4 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product Portfolio
6.9.5 DAIICHI SANKYO COMPANY Recent Developments/Updates
6.10 Purdue Pharma
6.10.1 Purdue Pharma Company Information
6.10.2 Purdue Pharma Description and Business Overview
6.10.3 Purdue Pharma Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Purdue Pharma Opioid Receptor Agonist Product Portfolio
6.10.5 Purdue Pharma Recent Developments/Updates
6.11 Hikma Pharmaceuticals
6.11.1 Hikma Pharmaceuticals Company Information
6.11.2 Hikma Pharmaceuticals Description and Business Overview
6.11.3 Hikma Pharmaceuticals Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hikma Pharmaceuticals Opioid Receptor Agonist Product Portfolio
6.11.5 Hikma Pharmaceuticals Recent Developments/Updates
6.12 Endo Pharmaceuticals
6.12.1 Endo Pharmaceuticals Company Information
6.12.2 Endo Pharmaceuticals Description and Business Overview
6.12.3 Endo Pharmaceuticals Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Endo Pharmaceuticals Opioid Receptor Agonist Product Portfolio
6.12.5 Endo Pharmaceuticals Recent Developments/Updates
6.13 Sun Pharmaceutical Industries
6.13.1 Sun Pharmaceutical Industries Company Information
6.13.2 Sun Pharmaceutical Industries Description and Business Overview
6.13.3 Sun Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sun Pharmaceutical Industries Opioid Receptor Agonist Product Portfolio
6.13.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.14 Tris Pharma
6.14.1 Tris Pharma Company Information
6.14.2 Tris Pharma Description and Business Overview
6.14.3 Tris Pharma Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Tris Pharma Opioid Receptor Agonist Product Portfolio
6.14.5 Tris Pharma Recent Developments/Updates
6.15 Indivior
6.15.1 Indivior Company Information
6.15.2 Indivior Description and Business Overview
6.15.3 Indivior Opioid Receptor Agonist Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Indivior Opioid Receptor Agonist Product Portfolio
6.15.5 Indivior Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioid Receptor Agonist Industry Chain Analysis
7.2 Opioid Receptor Agonist Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioid Receptor Agonist Production Mode & Process Analysis
7.4 Opioid Receptor Agonist Sales and Marketing
7.4.1 Opioid Receptor Agonist Sales Channels
7.4.2 Opioid Receptor Agonist Distributors
7.5 Opioid Receptor Agonist Customer Analysis
8 Opioid Receptor Agonist Market Dynamics
8.1 Opioid Receptor Agonist Industry Trends
8.2 Opioid Receptor Agonist Market Drivers
8.3 Opioid Receptor Agonist Market Challenges
8.4 Opioid Receptor Agonist Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Teva Pharmaceutical Industries
Johnson & Johnson
Pfizer Inc
Fresenius Kabi
Mylan N.V.
Allergan plc
US WorldMeds
Piramal Critical Care
Daiichi Sankyo Company
Purdue Pharma
Hikma Pharmaceuticals
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Tris Pharma
List of Tables
 Table 1. Global Opioid Receptor Agonist Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Opioid Receptor Agonist Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Opioid Receptor Agonist Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Opioid Receptor Agonist Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Opioid Receptor Agonist Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Opioid Receptor Agonist Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Opioid Receptor Agonist Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Opioid Receptor Agonist Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Opioid Receptor Agonist, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Opioid Receptor Agonist, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Opioid Receptor Agonist, Product Type & Application
 Table 12. Global Key Manufacturers of Opioid Receptor Agonist, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Opioid Receptor Agonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Receptor Agonist as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Opioid Receptor Agonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Opioid Receptor Agonist Sales by Region (2020-2025) & (K Units)
 Table 18. Global Opioid Receptor Agonist Sales Market Share by Region (2020-2025)
 Table 19. Global Opioid Receptor Agonist Sales by Region (2026-2031) & (K Units)
 Table 20. Global Opioid Receptor Agonist Sales Market Share by Region (2026-2031)
 Table 21. Global Opioid Receptor Agonist Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Opioid Receptor Agonist Revenue Market Share by Region (2020-2025)
 Table 23. Global Opioid Receptor Agonist Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Opioid Receptor Agonist Revenue Market Share by Region (2026-2031)
 Table 25. North America Opioid Receptor Agonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Opioid Receptor Agonist Sales by Country (2020-2025) & (K Units)
 Table 27. North America Opioid Receptor Agonist Sales by Country (2026-2031) & (K Units)
 Table 28. North America Opioid Receptor Agonist Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Opioid Receptor Agonist Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Opioid Receptor Agonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Opioid Receptor Agonist Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Opioid Receptor Agonist Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Opioid Receptor Agonist Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Opioid Receptor Agonist Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Opioid Receptor Agonist Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Opioid Receptor Agonist Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Opioid Receptor Agonist Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Opioid Receptor Agonist Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Opioid Receptor Agonist Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Opioid Receptor Agonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Opioid Receptor Agonist Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Opioid Receptor Agonist Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Opioid Receptor Agonist Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Opioid Receptor Agonist Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Opioid Receptor Agonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Opioid Receptor Agonist Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Opioid Receptor Agonist Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Opioid Receptor Agonist Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Opioid Receptor Agonist Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Opioid Receptor Agonist Sales (K Units) by Type (2020-2025)
 Table 51. Global Opioid Receptor Agonist Sales (K Units) by Type (2026-2031)
 Table 52. Global Opioid Receptor Agonist Sales Market Share by Type (2020-2025)
 Table 53. Global Opioid Receptor Agonist Sales Market Share by Type (2026-2031)
 Table 54. Global Opioid Receptor Agonist Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Opioid Receptor Agonist Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Opioid Receptor Agonist Revenue Market Share by Type (2020-2025)
 Table 57. Global Opioid Receptor Agonist Revenue Market Share by Type (2026-2031)
 Table 58. Global Opioid Receptor Agonist Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Opioid Receptor Agonist Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Opioid Receptor Agonist Sales (K Units) by Application (2020-2025)
 Table 61. Global Opioid Receptor Agonist Sales (K Units) by Application (2026-2031)
 Table 62. Global Opioid Receptor Agonist Sales Market Share by Application (2020-2025)
 Table 63. Global Opioid Receptor Agonist Sales Market Share by Application (2026-2031)
 Table 64. Global Opioid Receptor Agonist Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Opioid Receptor Agonist Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Opioid Receptor Agonist Revenue Market Share by Application (2020-2025)
 Table 67. Global Opioid Receptor Agonist Revenue Market Share by Application (2026-2031)
 Table 68. Global Opioid Receptor Agonist Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Opioid Receptor Agonist Price (US$/Unit) by Application (2026-2031)
 Table 70. Teva Pharmaceutical Industries Company Information
 Table 71. Teva Pharmaceutical Industries Description and Business Overview
 Table 72. Teva Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Teva Pharmaceutical Industries Opioid Receptor Agonist Product
 Table 74. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 75. Johnson & Johnson Company Information
 Table 76. Johnson & Johnson Description and Business Overview
 Table 77. Johnson & Johnson Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Johnson & Johnson Opioid Receptor Agonist Product
 Table 79. Johnson & Johnson Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Opioid Receptor Agonist Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Fresenius Kabi Company Information
 Table 86. Fresenius Kabi Description and Business Overview
 Table 87. Fresenius Kabi Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Fresenius Kabi Opioid Receptor Agonist Product
 Table 89. Fresenius Kabi Recent Developments/Updates
 Table 90. Mylan N.V. Company Information
 Table 91. Mylan N.V. Description and Business Overview
 Table 92. Mylan N.V. Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Mylan N.V. Opioid Receptor Agonist Product
 Table 94. Mylan N.V. Recent Developments/Updates
 Table 95. Allergan Company Information
 Table 96. Allergan Description and Business Overview
 Table 97. Allergan Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Allergan Opioid Receptor Agonist Product
 Table 99. Allergan Recent Developments/Updates
 Table 100. US WorldMeds Company Information
 Table 101. US WorldMeds Description and Business Overview
 Table 102. US WorldMeds Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. US WorldMeds Opioid Receptor Agonist Product
 Table 104. US WorldMeds Recent Developments/Updates
 Table 105. Piramal Critical Care Company Information
 Table 106. Piramal Critical Care Description and Business Overview
 Table 107. Piramal Critical Care Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Piramal Critical Care Opioid Receptor Agonist Product
 Table 109. Piramal Critical Care Recent Developments/Updates
 Table 110. DAIICHI SANKYO COMPANY Company Information
 Table 111. DAIICHI SANKYO COMPANY Description and Business Overview
 Table 112. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product
 Table 114. DAIICHI SANKYO COMPANY Recent Developments/Updates
 Table 115. Purdue Pharma Company Information
 Table 116. Purdue Pharma Description and Business Overview
 Table 117. Purdue Pharma Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Purdue Pharma Opioid Receptor Agonist Product
 Table 119. Purdue Pharma Recent Developments/Updates
 Table 120. Hikma Pharmaceuticals Company Information
 Table 121. Hikma Pharmaceuticals Description and Business Overview
 Table 122. Hikma Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Hikma Pharmaceuticals Opioid Receptor Agonist Product
 Table 124. Hikma Pharmaceuticals Recent Developments/Updates
 Table 125. Endo Pharmaceuticals Company Information
 Table 126. Endo Pharmaceuticals Description and Business Overview
 Table 127. Endo Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Endo Pharmaceuticals Opioid Receptor Agonist Product
 Table 129. Endo Pharmaceuticals Recent Developments/Updates
 Table 130. Sun Pharmaceutical Industries Company Information
 Table 131. Sun Pharmaceutical Industries Description and Business Overview
 Table 132. Sun Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Sun Pharmaceutical Industries Opioid Receptor Agonist Product
 Table 134. Sun Pharmaceutical Industries Recent Developments/Updates
 Table 135. Tris Pharma Company Information
 Table 136. Tris Pharma Description and Business Overview
 Table 137. Tris Pharma Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Tris Pharma Opioid Receptor Agonist Product
 Table 139. Tris Pharma Recent Developments/Updates
 Table 140. Indivior Company Information
 Table 141. Indivior Description and Business Overview
 Table 142. Indivior Opioid Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Indivior Opioid Receptor Agonist Product
 Table 144. Indivior Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Opioid Receptor Agonist Distributors List
 Table 148. Opioid Receptor Agonist Customers List
 Table 149. Opioid Receptor Agonist Market Trends
 Table 150. Opioid Receptor Agonist Market Drivers
 Table 151. Opioid Receptor Agonist Market Challenges
 Table 152. Opioid Receptor Agonist Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Opioid Receptor Agonist
 Figure 2. Global Opioid Receptor Agonist Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Opioid Receptor Agonist Market Share by Type: 2024 & 2031
 Figure 4. Fentanyl Product Picture
 Figure 5. Codeine Product Picture
 Figure 6. Morphine Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Opioid Receptor Agonist Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Opioid Receptor Agonist Market Share by Application: 2024 & 2031
 Figure 10. Hospital Pharmacy
 Figure 11. Online Pharmacy
 Figure 12. Retail Pharmacy
 Figure 13. Global Opioid Receptor Agonist Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Opioid Receptor Agonist Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Opioid Receptor Agonist Sales (2020-2031) & (K Units)
 Figure 16. Global Opioid Receptor Agonist Average Price (US$/Unit) & (2020-2031)
 Figure 17. Opioid Receptor Agonist Report Years Considered
 Figure 18. Opioid Receptor Agonist Sales Share by Manufacturers in 2024
 Figure 19. Global Opioid Receptor Agonist Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Opioid Receptor Agonist Players: Market Share by Revenue in Opioid Receptor Agonist in 2024
 Figure 21. Opioid Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Opioid Receptor Agonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Opioid Receptor Agonist Sales Market Share by Country (2020-2031)
 Figure 24. North America Opioid Receptor Agonist Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Opioid Receptor Agonist Sales Market Share by Country (2020-2031)
 Figure 28. Europe Opioid Receptor Agonist Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Opioid Receptor Agonist Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Opioid Receptor Agonist Revenue Market Share by Region (2020-2031)
 Figure 36. China Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Opioid Receptor Agonist Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Opioid Receptor Agonist Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Opioid Receptor Agonist Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Opioid Receptor Agonist Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Opioid Receptor Agonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Opioid Receptor Agonist by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Opioid Receptor Agonist by Type (2020-2031)
 Figure 58. Global Opioid Receptor Agonist Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Opioid Receptor Agonist by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Opioid Receptor Agonist by Application (2020-2031)
 Figure 61. Global Opioid Receptor Agonist Price (US$/Unit) by Application (2020-2031)
 Figure 62. Opioid Receptor Agonist Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Opioids Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Opioids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Opioid Narcotics Market Research Report 2024
Global Opioids Drug Market Research Report 2025
Opioid Induced Side Effects Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Apomorphine Delivery Device Market Insights Forecast to 2030
Global Opioid Drugs Market Insights Forecast to 2030
Global Dopamine Receptor Agonists Market Research Report 2025
Global Melanocortin Receptor Agonist Drugs Market Research Report 2024
Gamma aminobutyric Acid GABA Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dopamine Receptor Agonists For PD Market Research Report 2025
Global Melanocortin Agonist Market Research Report 2024
Global Apomorphine Hydrochloride Market Insights Forecast to 2030
Global GABAB Receptor Agonists Market Research Report 2025
Oxycodone Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tapentadol Market Research Report 2024
Global Apomorphine Hydrochloride Injection Market Insights Forecast to 2030
Global Long acting Melatonin Receptor Agonists Market Research Report 2025
Global Opioid Use Disorder Market Insights Forecast to 2030
Global Tapentadol Tablets Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions